New supplementation proposals for pregnant women with foetal cardiac diseases

Background: The incidence of maternal cardiac diseases has an adverse effect on pregnancy outcomes. The present study was done the objective to determine the Incidence and distribution of cardiac disease in pregnant patients, to assess mode of delivery and fetomaternal outcome in pregnancy with heart disease patients.Methods: This was a hospital based prospective observational study that include 65 pregnant women with diagnosed cardiac disease or had symptoms and signs suggestive of cardiac disease during the period from January 2018 to December 2019. Baseline data recorded including age, parity, gestational age, cardiac lesions, New York heart association (NYHA) functional class, use of cardiac medications, thorough clinical examination including chest and cardiovascular auscultation, ECG and echocardiographic assessment of left and right ventricular systolic function. Fetomaternal outcome was analysed in the study.Results: The mean age of the patients was 24.33±2.93 years (ranging from 19-36 years). 34 patients (52.30%) were primigravida. Majority (58.46%) cases were from rural area. Majority patients (70.77%) are present between 37-40 weeks of gestational age. Most of patients had vaginal delivery (64.62%). 43 patients (66.15%) diagnosed with heart disease after pregnancy, while 22 patients (33.85%) are diagnosed before pregnancy for heart disease. Neonatal complications were seen in in 35.38% of patients. Cardiac complications were present in 40% of patients. majority of fetal complications are in nonoperated patients (46.15%).Conclusion: The management of pregnant women with cardiac diseases requires multidisciplinary approach to prevent morbidity and mortality. It is necessary to optimize healthcare facilities to obtain maximum maternal and fetal outcome.

Download Full-text

Prediction of complications in pregnant women with cardiac diseases referred to a tertiary center

International Journal of Cardiology ◽

10.1016/j.ijcard.2010.05.045 ◽

2011 ◽

Vol 151 (2) ◽

pp. 209-213 ◽

Cited By ~ 42

Author(s):

Nicole Jastrow ◽

Philippe Meyer ◽

Paul Khairy ◽

Lise-Andrée Mercier ◽

Annie Dore ◽

...

Keyword(s):

Pregnant Women ◽

Cardiac Diseases ◽

Tertiary Center ◽

Prediction Of Complications

Download Full-text

Cardiac emergencies in pregnancy

10.1093/med/9780199687039.003.0063 ◽

2015 ◽

Author(s):

Patrizia Presbitero ◽

Dennis Zavalloni ◽

Benedetta Agnoli

Keyword(s):

Pregnant Women ◽

Rare Event ◽

Cardiac Care ◽

Cardiac Diseases ◽

Fetal Protection ◽

Physiological Processes ◽

Pathological Conditions ◽

Cardiac Emergencies ◽

Undiagnosed Diseases ◽

Cardiac Care Unit

Cardiac diseases are an increasingly important cause of morbidity and mortality in pregnant women. Pregnancy leads to several changes in physiological processes, and the cardiovascular system progressively adapts to modifications that may worsen pre-existing pathological conditions or unmask previously undiagnosed diseases. Furthermore, pregnancy may be complicated by specific pathologies, which are harmful for patients with cardiac diseases. Admission to the intensive cardiac care unit is a rare event (0.1–0.9% of deliveries), but mortality rates range from 3.5% to 21%. When treating pregnant women, we are taking care of two subjects: the mother and the fetus. The possible adverse effects of diagnostic examination and/or therapies on the fetus should always be considered, and, even after delivery, possible drug interactions on breastfeeding should be taken in account. In this chapter, an overview on the main cardiac emergencies that may affect pregnancy is provided, with a particular focus on treatments allowed for both mother and fetal protection.

Download Full-text